All News #Library
Others
Mythic Mytx-011 Kis Met Phase 1: Asco 2024 Annual Meeting Data
23 May 2024 //
BUSINESSWIRE
Mythic Therapeutics MYTX-011 Preclinical Data Published
30 Apr 2024 //
BUSINESSWIRE
Mythic Therapeutics Appoints George Eliades, Ph.D., as President and CEO
28 Mar 2024 //
BUSINESSWIRE
Mythic Therapeutics Receives FDA Fast Track Designation for MYTX-011
26 Sep 2023 //
BUSINESSWIRE

Market Place
Sourcing Support